Role of the Cytosine Dna-Methyltransferase and p16^nk4a Genes in the Development of Mouse Lung Tumors

References

• Laird P W, Jaenisch R. DNA methylation and cancer. Hum Mol Genet. 1993; 3: 1487–1495
   Web of Science ®Google Scholar
• Singer-Sam J, Riggs A D. X chromosome inactivation and DNA methylation. EXS. 1993; 64: 358–384
   PubMedGoogle Scholar
• Bartolomei M S, Webber A L, Brunkow M E, Tilghman S M. Epigenetic mechanisms underlying the imprinting of the mouse H19 gene. Genes Dev. 1993; 7: 1663–1673
   PubMed Web of Science ®Google Scholar
• Bird A P. CpG-rich islands and the function of DNA methylation. Nature 1986; 321: 209–213
   PubMed Web of Science ®Google Scholar
• deBustros A, Nelkin B D, Silverman A, Ehrlich G, Poiesz B, Baylin S B. The short arm of chromosome 11 is a “hot spot” for hypermethylation in human neoplasia. Proc Natl Acad Sci USA. 1988; 85: 5693–5697
   PubMed Web of Science ®Google Scholar
• Makos M, Nelkin B D, Lerman M I, Latif F, Zbar B, Baylin S B. Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc Natl Acad Sci USA. 1992; 89: 1929–1933
   PubMed Web of Science ®Google Scholar
• Herman J G, Latif F, Yongkai W, et al. Silencing of the VHL tumor-supressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA. 1994; 91: 9700–9704
   PubMed Web of Science ®Google Scholar
• Issa J -PJ, Ottaviano Y L, Celano P, Hamilton S R, Davidson N E, Baylin S B. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nature Genet. 1994; 7: 536–540
   PubMed Web of Science ®Google Scholar
• Merlo A, Herman J G, Mao L, et al. CpG island methylation is associated with inactivation of the tumor suppressor CDKN/p16 in human tumors. Nature Med. 1995; 1: 686–692
   PubMed Web of Science ®Google Scholar
• Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S. Silencing of the E-cadherin invasion-suppressor gene by CpG island methylation in human carcinomas. Proc Natl Acad Sci USA. 1995; 92: 7416–7419
   PubMed Web of Science ®Google Scholar
• Makos M W, Biel M A, Deiry W E, et al. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nature Med. 1995; 6: 570–577
   Google Scholar
• Greenblatt M S, Bennett W P, Hollstein M, Harris C C. Mutations in the p53 tumor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994; 54: 4855–4878
   PubMed Web of Science ®Google Scholar
• Weinberg R A. The retinoblastoma protein and cell cycle control. Cell. 1995; 81: 323–330
   PubMed Web of Science ®Google Scholar
• Kamb A, Gruis N A, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436–439
   PubMed Web of Science ®Google Scholar
• Merlo A, Herman J G, Mao L, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nature Med. 1995; 1: 686–692
   PubMed Web of Science ®Google Scholar
• Otterson G A, Kratze R A, Coxon A, Kim Y W, Kaye F J. Absence of p16INK4a protein is restricted to the subset of lung cancer lines that retains wildtype Rb. Oncogene. 1994; 9: 3375–3378
   PubMed Web of Science ®Google Scholar
• Quelle D E, Ashmun R A, Hannon G J, et al. Cloning and characterization of murine p16^INK4a and p15^INK4b genes oncogene. 1995; 11: 635–645
   Google Scholar
• Xiao S, Daizong L, Corson J M, Vijg J, Fletcher J A. Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma. Cancer Res. 1995; 55: 2968–2971
   PubMed Web of Science ®Google Scholar
• Davis L M, Caspary W J, Sakallah S A, et al. Loss of heterozygosity in spontaneous and chemically induced tumors of the B6C3F1 mouse. Carcinogenesis. 1994; 15: 1637–1645
   PubMed Web of Science ®Google Scholar
• Herzog C R, Wiseman R W, You M. Deletion mapping of a putative tumor suppressor gene on chromosome 4 in mouse lung tumors. Cancer Res. 1994; 54: 4007–4010
   PubMed Web of Science ®Google Scholar
• Funaki K, Everitt J, Oshimura M, Freed J J, Knudson A G, Walker C. Hereditary renal cell carcinoma in the rat associated with nonrandom loss of chromosomes 5 and 6. Cancer Res. 1991; 51: 4415–4422
   PubMed Web of Science ®Google Scholar
• Harbour J W, Lai S -L, Whang-Peng J, Gazda A F, Minna J F, Kaye J F. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 1988; 241: 353–357
   PubMed Web of Science ®Google Scholar
• Bestor T, Laudano A, Mattaliano R, Ingram V. Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. J Mol Biol. 1988; 203: 971–983
   PubMed Web of Science ®Google Scholar
• Issa J -PJ, Vertino P M, Wu J, et al. Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst. 1993; 85: 1235–1240
   PubMed Web of Science ®Google Scholar
• Wu J, Issa J -P, Herman J, Bassett D E, Nelkin B D, Baylin S B. Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. Proc Natl Acad Sci USA. 1993; 90: 8891–8895
   PubMed Web of Science ®Google Scholar
• Laird P W, Jackson-Grusby L, Fazeli A, et al. Suppression of intestinal neoplasia by DNA hypo-methylation. Cell. 1995; 81: 197–205
   PubMed Web of Science ®Google Scholar
• Belinsky S A, Nikula K J, Baylin S B, Issa J -PJ. Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer. Proc Natl Acad Sci. USA. 1996; 93: 4045–4050
   PubMed Web of Science ®Google Scholar
• Belinsky S A, Swafford D S, Middleton S K, Kennedy C H, Tesfaigzi J. Deletion and differential expression of p16INK4a in mouse lung tumors. Carcinogenesis. 1996; 17: 101–106
   Google Scholar
• Belinsky S A, Lechner J F, Johnson N F. An improved method for the isolation of type II and Clara cells from mice. In Vitro Cell Dev Biol. 1995; 31: 361–366
   Web of Science ®Google Scholar
• Belinsky S A, Devereux T R, Foley J F, Maronpot R R, Anderson M W. Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4- (methylnitrosamino)-1- (3-pyridyl)-1-butanone in the A/J mouse. Cancer Res. 1992; 52: 3164–3173
   PubMed Web of Science ®Google Scholar
• Adams R LP, Rinaldi A, Seivwright C. Microassay for DNA methyltransferase. J Biochem Biophys Methods. 1991; 22: 19–22
   PubMedGoogle Scholar
• Quelle D E, Ashmum R A, Hannon G J, et al. Cloning and characterization of murine p16INK4a and p15INK4b genes. Oncogene. 1995; 11: 635–645
   PubMed Web of Science ®Google Scholar
• Malkinson A. The genetic basis of susceptibility to lung tumors in mice. Toxicology. 1989; 54: 241–271
   PubMed Web of Science ®Google Scholar
• Shapiro G I, Edwards C D, Kobzik L, et al. Reciprocal Rb inactivation and p16INK4a expression in primary lung cancers and cell lines. Cancer Res. 1995; 55: 505–509
   PubMed Web of Science ®Google Scholar
• Yang R, Gombart A F, Serrano M, Koeffler H P. Mutational effects on the p16INK4a tumor suppressor protein. Cancer Res. 1995; 55: 2503–2506
   PubMed Web of Science ®Google Scholar
• MacLeod A R, Szyf M. Expression of antisense to DNA methyltransferase mRNA induces DNA demethylation and inhibits tumorigenesis. J Biol Chem. 1995; 270: 8037–8043
   PubMed Web of Science ®Google Scholar
• Hammond W G, Yellin A, Gabriel A, et al. Effects of 5-azacytidine in Syrian golden hamsters: toxicity, tumorigenicity, and differential modulation of bronchial carcinogenesis. Exp Mol Pathol. 1990; 53: 34–51
   PubMed Web of Science ®Google Scholar
• Antequera F, Boyes J, Bird A P. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell. 1990; 62: 503–514
   PubMedGoogle Scholar
• de Bustros A, Nelkin B D, Silverman A, Ehrlich G, Poiesz B, Baylin S B. The short arm of chromosome 11 is a “hotspot” for hypermethylation in human neoplasia. Proc Natl Acad Sci USA. 1988; 85: 5693–5697
   PubMed Web of Science ®Google Scholar
• Swafford D S, Middleton S K, Palmisano W A, et al. Frequent aberrant methylation of p16INK4a in primary rat lung tumors. Mol Cell Biol. 1997; 17: 1366–1374
   PubMed Web of Science ®Google Scholar
• Belinsky S A, Swafford D S, Finch G L, et al. Alterations in the K-ras and p53 genes in rat lung tumors. Environ Health Perspect. 1997; 105: 901–906
   PubMed Web of Science ®Google Scholar
• Barker D, Schafer M, White R. Restriction sites containing CpG show a higher frequency of polymorphism in human DNA. Cell. 1984; 36: 131–138
   PubMed Web of Science ®Google Scholar
• Rideout W M, Coetzee G A, Olumi A F, Jones P A. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 1990; 249: 1288–1290
   PubMed Web of Science ®Google Scholar
• Hegi M, Devereux T R, Dietrich W F, et al. Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalance on chromosome 6 and K-ras activation. Cancer Res. 1994; 54: 6257–6264
   PubMed Web of Science ®Google Scholar
• Woloschak M, Yu A, Xiao J, Post K D. Frequent loss of the p16INK4a gene product in human pituitary tumors. Cancer Res. 1996; 56: 2493–2496
   PubMed Web of Science ®Google Scholar
• Okamoto A, Demetrick D J, Spillare E A, et al. Mutations and altered expression of p16INK4a in human cancer. Proc. Natl. Acad Sci USA. 1994; 91: 11045–11049
   PubMed Web of Science ®Google Scholar
• Shapiro G I, Edwards C D, Kobzik L, et al. Reciprocal Rb inactivation and p16INK4a expression in primary lung cancers and cell lines. Cancer Res. 1995; 55: 505–509
   PubMed Web of Science ®Google Scholar
• Nishikawa R, Furnari F B, Lin H, et al. Loss of p16INK4a expression is frequent in high grade gliomas. Cancer Res. 1995; 55: 1941–1945
   PubMed Web of Science ®Google Scholar
• Linardopoulos S, Street A J, Quelle D E, Parry D, Peters G, Sherr C J. Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors. Cancer Res. 1995; 55: 5168–5172
   PubMed Web of Science ®Google Scholar
• Knapek D F, Serrano M, Beach D, Trono D, Walker C L. Association of rat p15INK4b/p16INK4 deletions with monosomy 5 in kidney epithelial cell lines but not primary renal tumors. Cancer Res. 1995; 55: 1607–1612
   PubMed Web of Science ®Google Scholar
• Herzog C R, Soloff E V, McDoniels A L, et al. Homozygous codeletion and differential decreased expression of p15INK4b p16INK4a-a and p16INK4a-b in mouse lung tumor cells. Oncogene. 1996; 13: 1885–1891
   PubMed Web of Science ®Google Scholar
• Sozzi G, Miozzo M, Donghi R, et al. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res. 1992; 52: 6079–6082
   PubMed Web of Science ®Google Scholar
• Crowell R, Gilliland F D, Temes R T, et al. Detection of trisomy 7 in nonmalignant bronchial epithelium from lung cancer patients and individuals at risk for lung cancer. Cancer Epidemiol Biomarkers Prev. 1996; 5: 631–637
   PubMed Web of Science ®Google Scholar
• Mao L, Lee J S, Kurie J M, et al. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst. 1997; 12: 857–862
   Google Scholar